Has Craig Selzman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,205 in general payments to Craig Selzman, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Selzman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Selzman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Selzman, MD

Vascular Surgery · Salt Lake City, UTNPI 1902991144

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 62.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $4,974 and has fallen 94.2% since, to $288 in 2025. Among vascular surgery clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,205in general payments, 2019–2025

Across 57 payments — averaging $196.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$7K
La Jolla Pharmaceutical Company$4K
Abbott$431
Paragonix Technologies, Inc.$138
Artivion, Inc.$24
Atricure, Inc.$21

$597,105in research payments, 2019–2025

Across 147 payments — averaging $4061.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$172K
Briohealth Solutions, Inc.$140K
Medtronic$109K
Edwards Lifesciences$75K
AstraZeneca$53K
Transmedics, Inc.$47K

What the payments were for

Consulting fees$4,55041%
Travel & lodging$4,35739%
Food & beverage$2,29821%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	49	$7,042
La Jolla Pharmaceutical Company	1	$3,550
Abbott	4	$431
Paragonix Technologies, Inc.	1	$138
Artivion, Inc.	1	$24
Atricure, Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GIAPREZA$3,550
MITRIS RESILIA Mitral Valve$2,021
PASCAL$1,469
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$296
SherpaPak$138
LIVERguard$138
LUNGguard$138
BaroGuard$138
PancreasPak$138

How this compares

$11,205 in reported general payments places this provider in the 90th percentile of 31 vascular surgery providers in Utah.

See all vascular surgery providers in Utah →

Medicare billing

Part B allowed, 2024

$140,055

Medicare patients

Services billed

392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	17	$20,178
FarxigaDapagliflozin Propanediol	17	$18,258
Potassium Chloride	53	$1,979
Bumetanide	29	$1,336
Digoxin	46	$1,259
Omeprazole	67	$843
Warfarin Sodium	44	$689
Atorvastatin Calcium	37	$480
Spironolactone	37	$401
Carvedilol	40	$328
Rosuvastatin Calcium	13	$305
Metoprolol Succinate	17	$252
Amiodarone Hcl	17	$228
Levothyroxine Sodium	12	$166
Losartan Potassium	14	$87

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Salt Lake City

Thomas SerenaSalt Lake City$8K
Holly RyanSalt Lake City$5K
Benjamin BrookeSalt Lake City$4K
Kaohinani LongwolfSalt Lake City$4K
Alexander SchurmanSalt Lake City$4K
Ian SchliederSalt Lake City$3K
Steven SimperSalt Lake City$2K
Mark SarfatiSalt Lake City$1K
Luke DegraaffSalt Lake City$881
Larry KraissSalt Lake City$716

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →